KLRS — Kalaris Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Kalaris Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	248	234	184	118	118
Net Total Receivables	0.05	0.157	0.206	0	—
Prepaid Expenses
Total Current Assets	253	243	188	119	119
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.3	32.6	2.19	—	1.48
Other Long Term Assets
Total Assets	287	277	191	119	122
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	37.9	24.3	28.4	5.24	9.71
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	61.3	52.6	45	5.24	42.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	225	225	146	113	78.8
Total Liabilities & Shareholders' Equity	287	277	191	119	122
Total Common Shares Outstanding